Recombinant human interferon-β in the treatment of condylomata acuminata

International Journal of STD and AIDS

Volumn 8, Issue 10, 1997, Pages 622-628

  Dinsmore, Wallace ^a   Jordan, Joe ^b   O'Mahony, Colm ^c   Harris, John R W ^d   McMillan, Alexander ^e   Radcliffe, Keith W ^f   Engrand, Patrick ^g   Jackson, Brian W ^g   Galazka, Andrew R ^g   Abdul Ahad, Ayad K ^g   Illingworth, John M ^g  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

^c Countess of Chester Hospital ^*  (United Kingdom)

^d ST MARY S HOSPITAL   (United Kingdom)

^e ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^f Whittall Street Clinic ^*  (United Kingdom)

^g Ares Services Inc   (Switzerland)

Author keywords

Condyloma lesions; Condylomata acuminata; Double blind; Placebo controlled trial; Recombinant human interferon

Indexed keywords

RECOMBINANT BETA INTERFERON;

ARTICLE; ASTHENIA; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; INJECTION; INTRADERMAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; CONDYLOMATA ACUMINATA; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRALESIONAL; INTERFERON-BETA; MALE; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 9844227905     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462971918887     Document Type: Article

References (15)

1. Condyloma acuminatum - United States 1966-1981. MMWR 1983;32:306-8
2. Reichman RC. Human papillomavirus infections. In: Wilson JD, Braunwald E, Isselbacher KJ, et al., eds. 150 Harrison's Principles of Internal Medicine, 12th edn. New York: McGraw-Hill Inc. 1991:741-3
3. Phelps WC, Alexander KA. Antiviral therapy for human papillomaviruses: rationale and prospects. Ann Int Med 1995;123:368-82
4. Beaudenon S, Kremsdorf D, Croissant O, et al. A novel type of human papillomavirus associated with genital neoplasias. Nature 1986;321:246-9
5. Kirby P. Interferon and genital warts: much potential, modest progress. JAMA 1988;259:570-2
6. Ferenczy A, Mitao M, Nagai N, et al. Latent papillomavirus and recurring genital warts. N Engl J Med 1985;313:784-8
7. Turek LP, Byrne JC, Lowry DR, et al. Interferon induces morphologic reversion with elimination of extrachromosomal viral genomes in bovine papillomavirus-transformed mouse cells. Proc Natl Acad Sci USA 1982;79:7914-18
8. Sica G, Lama G, Tartaglione R, et al. Effects of natural beta-interferon and recombinant alpha-2b-interferon on proliferation, glucocorticoid receptor content, and antigen expression in cultured HL-60 cells. Cancer 1990;65:920-5
9. Borden EC, Groveman DS, Nasu T, et al. Antiproliferative activities of interferons against human bladder carcinoma cell lines in vitro. J Urol 1984;132:800-3
10. Johns TG, Mackay IR, Callister KA, et al. Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of Interferon β. J Natl Cancer Inst 1992;84:1185-9
11. De Marco F, Giannoni F, Marcante ML. Interferon-β strong cytopathic effect on human papillomavirus type 16-immortalized HPK-IA cell line, unexpectedly not shared by interferon-α. J Gen Virol 1995;76:445-50
12. Schonfeld A, Schattner A, Crespi M, et al. Intramuscular human interferon-β injections in the treatment of condylomata acuminata. Lancet 1984;i:1038-42
13. Reichman RC, Oakes D, Bonnez W, et al. Treatment of condyloma acuminatum with three different interferons administered intralesionally. Ann Intern Med 1988;108:675-9
14. Vance JC, Bart BJ, Hansen RC, et al. Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantaris. Arch Dermatol 1986;122:272-7
15. Eron LJ, Judson F, Tucker S, et al. Interferon therapy for condylomata acuminata. N Engl J Med 1986;315:1059-64